I expect the next PR will be they missed required milestonesand therefore the financiers will not extend the next installment of funds. The inevitable result of this will be the company will run out of money since it appears they are not where near selling anything to generate revenue and I am not aware that official FDA studies have even started. I expect that the company will then become private and current shareholders will be out in the cold. Just an opinion but seems likely speculation with the facts we know currently.